These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6517544)

  • 21. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
    Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P
    Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro synergy studies with ciprofloxacin and selected beta-lactam agents and aminoglycosides against multidrug-resistant Pseudomonas aeruginosa.
    Meyer RD; Liu S
    Diagn Microbiol Infect Dis; 1988 Nov; 11(3):151-7. PubMed ID: 3149927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro killing activity of combinations of beta-lactam agents with aminoglycosides against penicillin-resistant pneumococci.
    Schlegel L; Sissia G; Fremaux A; Geslin P
    J Antimicrob Chemother; 1997 Jan; 39(1):95-8. PubMed ID: 9044034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro comparison of aminoglycoside activities and their synergistic action with piperacillin.
    Hoogkamp-Korstanje JA
    Infection; 1985; 13(1):39-42. PubMed ID: 3988352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates.
    Owens RC; Banevicius MA; Nicolau DP; Nightingale CH; Quintiliani R
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2586-8. PubMed ID: 9371376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro comparison of Pseudomonas aeruginosa isolates with various susceptibilities to aminoglycosides and ten beta-lactam antibiotics.
    Wu DH; Baltch AL; Smith RP
    Antimicrob Agents Chemother; 1984 Apr; 25(4):488-90. PubMed ID: 6428308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
    Medeiros AA; Hare R; Papa E; Adam C; Miller GH
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens.
    Kurtz TO; Winston DJ; Bruckner DA; Martin WJ
    Antimicrob Agents Chemother; 1981 Aug; 20(2):239-43. PubMed ID: 6792982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa.
    Cappelletty DM; Rybak MJ
    Antimicrob Agents Chemother; 1996 Mar; 40(3):677-83. PubMed ID: 8851592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fortimicins A and B, new aminoglycoside antibiotics. IV. In vitro study of fortimicin A compared with other aminoglycosides.
    Girolami RL; Stamm JM
    J Antibiot (Tokyo); 1977 Jul; 30(7):564-70. PubMed ID: 19409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-lactam/aminoglycoside combinations: interactions and their mechanisms.
    Moellering RC; Eliopoulos GM; Allan JD
    Am J Med; 1986 May; 80(5C):30-4. PubMed ID: 3717186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations.
    Chow AW; Wong J; Bartlett KH; Shafran SD; Stiver HG
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1368-72. PubMed ID: 2508546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
    Fass RJ
    Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiply drug-resistant Pseudomonas maltophilia.
    Chow AW; Wong J; Bartlett KH
    Antimicrob Agents Chemother; 1988 May; 32(5):782-4. PubMed ID: 3395107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cefotaxime aminoglycoside interactions.
    Pierce MA; Elliott AM; Cobbs CG
    Chemotherapy; 1985; 31(5):336-45. PubMed ID: 4053733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of cefsulodin, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa.
    Chandrasekar PH; Schell RF; LeFrock JL; Rolston KV; Francisco M
    Chemotherapy; 1984; 30(3):165-9. PubMed ID: 6428812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative bactericidal activity of beta-lactam-aminoglycoside combinations against Pseudomonas aeruginosa].
    Cluzel M; Chanal M; Sirot J; Cluzel R
    Nouv Presse Med; 1982 Nov; 11(46):3400-4. PubMed ID: 6818523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination effect of piperacillin with four aminoglycosides on nonfermenting gram-negative bacteria.
    Daschner F; Langmaack H; Grehn M; Steffens A; Just M
    Chemotherapy; 1981; 27(1):39-43. PubMed ID: 6452252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative antibacterial activities of new beta-lactam antibiotics against Pseudomonas aeruginosa.
    Fernandes CJ; Stevens DA; Ackerman VP
    Chemotherapy; 1985; 31(4):292-6. PubMed ID: 3928282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
    Husson MO; Izard D; Leclerc H
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):466-8. PubMed ID: 3911141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.